Keyphrases
Purkinje Cell
100%
Neuroprotective
100%
Cholecystokinin Receptor
100%
Cholecystokinin
100%
Pcp2
100%
Cerebellum
60%
ATXN1
60%
Spinocerebellar Ataxia
40%
Ataxia
40%
Receptor Agonist
40%
Motor Performance
40%
Purkinje Cell Degeneration
40%
ATXN2
40%
MTORC1 Signaling
20%
Neurodegeneration
20%
Mouse Model
20%
Genetic Disease
20%
Therapeutic Potential
20%
Disease Treatment
20%
Cell Dysfunction
20%
Putative Drug Targets
20%
Receptor Activation
20%
Cell Loss
20%
Degenerative Disease
20%
RNA Sequencing (RNA-seq)
20%
Cell-Associated
20%
SCA2
20%
Calbindin
20%
Virtual Exhibition
20%
Purkinje Neuron
20%
Cerebellar Purkinje Cell
20%
Cell Pathology
20%
Pharmacology, Toxicology and Pharmaceutical Science
Receptor
100%
Neuroprotective Agent
100%
Cholecystokinin
100%
Cholecystokinin A Receptor
100%
Receptor Agonist
66%
Spinocerebellar Degeneration
66%
Cell Degeneration
66%
Ataxia
66%
Diseases
66%
Mouse Model
33%
Genetic Disorder
33%
Nerve Cell Degeneration
33%
Vitamin D-Dependent Calcium-Binding Protein
33%
Degenerative Disease
33%
Neuroscience
Neuroprotective Agent
100%
Purkinje Cell
100%
Cholecystokinin
100%
Cholecystokinin A Receptor
100%
Cerebellum
42%
Receptor
42%
Receptor Agonists
28%
Cell Degeneration
28%
Spinocerebellar Ataxia
28%
Ataxia
28%
Calbindin
14%
RNA-Seq
14%
Cell Loss
14%
Nerve Cell Degeneration
14%
Veterinary Science and Veterinary Medicine
Purkinje Cell
100%
Cholecystokinin
100%
Mouse
85%
Ataxia
57%
Diseases
57%
Cerebellum
42%
RNA-Seq
14%